Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Wearable Injectors Market worth $21.0 billion by 2031 - Exclusive Report by MarketsandMarkets™

      This image opens in the lightbox

      News provided by

      MarketsandMarkets

      18 Nov, 2026, 15:30 GMT

      Share this article

      Share this article


      DELRAY BEACH, Fla., Nov. 18, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Wearable Injectors Market is projected to reach USD 21.0 billion by 2031 from USD 12.6 billion in 2026, at a CAGR of 10.8% during the forecast period.

      Browse 380 market data Tables and 80 Figures spread through 500 Pages and in-depth TOC on 'Wearable Injectors Market- Global Forecast to 2031'

      Wearable Injectors Market Size & Forecast:

      • Market Size Available for Years: 2026–2031
      • 2026 Market Size: USD 12.6 billion
      • 2031 Projected Market Size: USD 21.0 billion
      • CAGR (2026–2031): 10.8%

      Wearable Injectors Market Trends & Insights:

      • By region, Asia Pacific is expected to have the highest CAGR from 2026 to 2031.
      • By product, the on-body wearable injectors segment accounted for a 60.8% share of the wearable injectors market in 2025.
      • By technology, the spring-based technology segment accounted for a 41.8% share of the wearable injectors market in 2025.
      • By usage, the reusable segment is expected to register the highest CAGR of 11.8% during the forecast period.

      Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004

      The expansion of the wearable injectors market is primarily driven by increased R&D activity, strategic partnerships and the use of artificial intelligence in diabetes management devices. Key contributing factors include the rising incidence of chronic diseases such as diabetes, cancer, cardiovascular disorders, and chronic respiratory illnesses. Additionally, the growth of the geriatric population and the escalating prevalence of obesity and hypertension are all instrumental in driving market growth. Companies are integrating digital health and remote monitoring with wearable injectors. Emerging markets such as India, Brazil, and Southeast Asia present lucrative opportunities in this market.

      Technological advancements are fundamentally transforming the wearable injectors market, notably through the integration of smart, connected, and automated systems powered by IoT and AI. Modern wearable injectors increasingly incorporate advanced features, including wireless AID technology and seamless smartphone integration. These innovations significantly enhance patient safety by mitigating medication errors while facilitating real-time monitoring and data analytics.

      By technology, the spring-based segment accounted for the largest market share in 2025.

      The spring-based technology segment accounted for the largest share in the wearable injectors market, driven by its reliability, simplicity, and cost-effectiveness. This technology uses mechanical spring mechanisms to deliver controlled, consistent drug flow, making it well suited for administering large-volume biologics and viscous drugs, especially in chronic conditions like cancer, diabetes, and autoimmune disorders. Its popularity also stems from ease of use, as spring-based injectors often require minimal user intervention and suit self-administration in home healthcare settings. The simpler mechanism enhances patient compliance and ensures safe drug delivery without complex electronic components. The combination of user-friendly design, compatibility with a broad range of drugs, and adaptability to both hospital and home-based settings has strengthened the spring-based technology segment's leading position in the wearable market.

      By therapeutic application, the autoimmune disease segment accounts for the largest share and the infectious diseases segment is expected to grow at the fastest CAGR in the market during the forecast period.

      The market, segmented into oncology, diabetes, autoimmune diseases, cardiovascular conditions, infectious diseases, rare/orphan disorders, and other applications, is currently dominated by the autoimmune segment. This is largely attributed to the rising global incidence of chronic autoimmune conditions such as rheumatoid arthritis, plaque psoriasis, and Crohn's disease, which require consistent administration of biologics. Additionally, a robust biologic pipeline, increasing approvals in autoimmune indications, and payer initiatives to reduce in-clinic treatment costs are driving adoption. The infectious diseases segment is expected to grow fastest, with the highest CAGR of 13.9% during the forecast period, supported by rising demand for self-administered biologics and expanding at-home treatment for chronic and acute infections. The diabetes segment also remains a significant application, driven by the increasing prevalence of diabetes and major technological advances in wearable injector devices, notably insulin pumps. A key factor driving this segment is the emergence of sophisticated insulin delivery systems, specifically hybrid closed-loop systems commonly referred to as artificial pancreas devices. These systems integrate continuous glucose monitoring (CGM) with automated insulin delivery, enabling precise insulin dose adjustments based on real-time glucose levels. Developments in accessible insulin pumps include touchscreen interfaces, customizable basal insulin rates, and seamless integration with mobile applications, all of which improve patient adherence to treatment protocols. Additionally, the escalating incidence of diabetes can be attributed to several contributing factors, including a growing geriatric demographic, increased consumption of alcohol and tobacco, and evolving lifestyle and dietary patterns, further fueling market growth in this domain.

      Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=100771004

      By region, North America accounted for the largest share of the market in 2025.

      In 2025, North America emerged as the dominant player in the wearable injectors market, primarily driven by substantial healthcare expenditures in the US. The Centers for Medicare & Medicaid Services (CMS) reported that US healthcare spending reached approximately USD 4.9 trillion in 2023, facilitating the uptake of advanced medical technologies such as smart wearable injectors across diverse healthcare environments. The region's robust healthcare infrastructure further bolsters its market presence, supported by an extensive network of hospitals and outpatient facilities. Major manufacturers such as BD, West Pharmaceutical Services, Inc., and Insulet Corporation, all headquartered in the US, expand access to innovative infusion technologies and accelerate market advancement. Moreover, the rising prevalence of chronic diseases and a growing geriatric population are additional catalysts for market growth, creating an increased demand for reliable wearable injectors. This synergy of high healthcare investment, advanced infrastructure, and an expanding patient demographic solidifies North America's position as a global leader in the wearable injectors market.

      Key Players

      Leading players in the Wearable Injectors companies include Medtronic (Ireland), BD (US), West Pharmaceutical Services, Inc. (US), Tandem Diabetes Care, Inc. (US), and Insulet Corporation (US).

      Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=100771004

      Wearable Injectors Market - Investment and Funding Scenario

      Investment Funding Context

      The wearable injectors market is seeing investment driven by expanding on-body drug delivery platforms, growing adoption of large-volume subcutaneous delivery, and strategic investments in connected drug delivery technologies. Investment activity fluctuated between 2020 and 2024, peaking in 2021, then moderating in subsequent years before recovering in 2024. In 2025, investment activity is estimated to have continued its gradual recovery, with deal activity and funding increasing moderately compared with 2024. Funding is estimated at approximately USD 170–190 million in 2025, reflecting renewed interest in wearable drug delivery platforms, biologics delivery, and strategic development of drug-device combination products.

      Revenue Shift Context

      The wearable injectors market is shifting from conventional injection approaches toward on-body delivery systems designed to administer larger drug volumes over extended periods, improve patient convenience, and support self-administration of biologic and specialty therapies. The global market is projected to increase from USD 12.6 billion in 2026 to USD 21.0 billion by 2031, at a CAGR of 10.8%. Growth opportunities include adoption of on-body injectors for biologics, development of drug-device combination products, and partnerships between pharmaceutical companies and device manufacturers to enable product-specific delivery platforms. Insulin delivery and other established wearable delivery applications provide an existing commercial base, while large-volume delivery of biologics and specialty medicines supports further expansion. Consequently, revenue opportunities are increasingly linked to integrated drug-device platforms and product-specific delivery solutions rather than hardware sales alone.

      Mergers and Acquisitions

      Mergers/acquisitions in the wearable injectors market for 2025 are on pace to exceed 2024 volume, with a rising share of higher-value deals, as buyers prioritize mature, platform-ready assets.

      WEARABLE INJECTORS MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–JULY 2026

      Month & Year

      Deal Type

      Company 1

      Company 2

      Description

      May 2026

      Acquisition

      embecta Corp. (US)

      Owen Mumford Holdings Limited (UK)

      embecta completed its acquisition of Owen Mumford for an upfront payment of GBP 100 million, with up to GBP 50 million in additional performance-based payments. The deal adds the Aidaptus next-generation autoinjector platform and broadens embecta's drug-delivery portfolio.

      January 2026

      Acquisition

      AbbVie Inc. (US)

      West Pharmaceutical Services (US)

      AbbVie announced an agreement to acquire West's Tempe manufacturing facility and associated intellectual property, including capabilities for the SmartDose 3.5 mL on-body injector.

      December 2025

      Acquisition

      Sempresto, Inc. (US)

      Alerje, Inc. (US)

      Sempresto acquired Alerje's smartphone-integrated autoinjector platform, including related intellectual property and physical assets. The transaction expands Sempresto's capabilities in connected emergency drug delivery.

      Company Revenue Share Details

      In the wearable injector device manufacturers market, the top five players account for approximately 89–99% of the total share, indicating a consolidated market. The competitive landscape includes established players such as Insulet Corporation (US), Medtronic (Ireland), Tandem Diabetes Care, Inc. (US), BD (US), and West Pharmaceutical Services, Inc. (US). These companies benefit from established drug delivery capabilities, technological expertise, and commercial experience in wearable insulin delivery and on-body injection systems. Competition is shaped by technological differentiation, pharmaceutical partnerships, and the development of next-generation wearable delivery platforms.

      In the wearable injector formulation manufacturers market, the top five players account for approximately 62–69% of the total share, indicating a consolidated competitive landscape. Key players include AbbVie Inc. (US), Amgen, Inc. (US), United Therapeutics Corporation (US), Apellis Pharmaceuticals, Inc. (US), and scPharmaceuticals Inc. (US). The market is supported by pharmaceutical companies with drug products suitable for delivery through wearable or on-body systems. Future competition will depend on the expansion of subcutaneous biologics, product-specific drug-device combinations, and the adoption of wearable delivery platforms for specialty medicines.

      Browse Adjacent Market: Medical Devices Market Research Reports &Consulting

      See More Latest Medical Devices Reports:

      Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031

      Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030

      About MarketsandMarkets™

      MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

      MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

      Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

      The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

      Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

      MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

      To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

      Contact:
      Mr. Rohan Salgarkar
      MarketsandMarkets™ INC.
      1615 South Congress Ave.
      Suite 103, Delray Beach, FL 33445
      USA: +1-888-600-6441
      Email: sales@marketsandmarkets.com
      Visit Our Website: https://www.marketsandmarkets.com/
      Research Insight: https://www.marketsandmarkets.com/ResearchInsight/wearable-injector-market.asp
      Content Source: https://www.marketsandmarkets.com/PressReleases/wearable-injector.asp

      Modal title

      Also from this source

      Building Information Modeling Market worth $18.51 billion by 2032 - Exclusive Report by MarketsandMarkets™

      Building Information Modeling Market worth $18.51 billion by 2032 - Exclusive Report by MarketsandMarkets™

      According to MarketsandMarkets™, the Building Information Modeling Market is projected to reach USD 18.51 billion by 2032 from USD 9.86 billion in...

      AIoT Market worth $126.58 billion by 2032 - Report by MarketsandMarkets™

      AIoT Market worth $126.58 billion by 2032 - Report by MarketsandMarkets™

      According to MarketsandMarkets™, the AIoT Market is estimated to reach USD 32.25 billion in 2026 and is projected to grow to USD 126.58 billion by...

      More Releases From This Source

      Explore

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Biotechnology

      Biotechnology

      Medical Equipment

      Medical Equipment

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.